Sleep Quality and Caregiver Burden in Children With Cerebral Palsy
This study is recruiting. It focuses on anxiety and currently lists participation information in Turkey.
Key information made simple
This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests in-person participation through a hospital, with sites including Istanbul Physical Medicine and Rehabilitation Training and research Hospital. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually meeting the main study requirements and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Recruitment status
- Recruiting
- Estimated enrollment
- Not clearly listed
- Sponsor
- Selim Sezikli
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Turkey
- Age range
- Over 2 Years
- Official registry ID
- NCT07168577
- Official source
- Official registry link
Want help reviewing this study?
Key study information
- Condition
- Anxiety, Depression, ...
- Study status
- Recruiting
- Sponsor / lead affiliation
- Selim Sezikli
- Location / country
- Turkey
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07168577
Why this study may matter
This study may matter because it adds public evidence around anxiety. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Turkey.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07168577
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with anxiety; age range: Over 2 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
Does a loved one or caregiver need to be involved?
The public registry appears to mention a loved one, caregiver, or family involvement. Ask whether that person must participate, provide information, attend visits, or simply be available if needed. The study team must confirm what is required.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Selim Sezikli, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
